The company

The pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications.

History

1995 Dr. Smit and his co-workers made a coincidental finding of increased autofluorescence of the skin in many diabetes patients when they were performing fluorescein capillary leakage studies in diabetes.
1996 Dr. Smit and Dr. Graaff developed dedicated prototypes to assess skin autofluorescence in human
1998 The first clinical studies in diabetes and renal failure were started with an advanced prototype of the AGE Reader in the University Hospital Groningen, the Netherlands
1999 Filed patent application for the AGE Reader and published the first scientific report on the clinical use of AGE Reader prototype in diabetic patients
2000 Initiated the first large scale follow-up study in the Zwolle region
2003 Dr. Smit and Dr. Graaff founded DiagnOptics in Groningen, the Netherlands
2004 The first clinical study on AGE Reader were published in Diabetologia
2005 AGE Reader was first shown to future users (EASD, Athens 2005)
2006 AGE Reader received CE approval for commercialization in Europe
2009 AGE Reader CU (Compact Unit) received CE approval
2010 DiagnOptics received ISO 13485 certification for its Quality Management System
2011 Diab-spot was first shown to future users (Prediabetes, Madrid 2011)
2011 Diab-spot received CE approval
2012 First demonstration of the AGE Reader mu at the EASD 2012 in Berlin
2013 AGE Reader mu received CE approval
2014 Installed base > 2000 units
2015 Ranked 33rd in Deloitte Technology Fast50 and sector winner Life Sciences
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

Contact

Our contact details

Diagnoptics Technologies B.V.
Aarhusweg 4-9
9723 JJ Groningen
The Netherlands

Tel: +31 (0)50 589 0612
Fax: +31 (0)50 589 0613
E-mail: info@diagnoptics.com


Follow us on LinkedIn
Follow us on Xing

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.